Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Neuroscience

Background:

• Adenosine receptors play crucial roles in various physiological processes.
• Selective modulation of adenosine receptor subtypes is a therapeutic target.
• Xanthine derivatives are known to interact with adenosine receptors.

Purpose of the Study:

• To synthesize and evaluate novel 8-styryl-1,3,7-alkylxanthine derivatives.
• To investigate their potency and selectivity as adenosine receptor antagonists.
• To identify structure-activity relationships for A2-selective antagonism.

Main Methods:

• Synthesis of substituted 8-styryl-1,3,7-alkylxanthine derivatives.
• Radioligand binding assays using rat brain A1 and A2 adenosine receptors.
• Structure-activity relationship analysis based on substituent modifications.

Main Results:

• Small hydrophobic substituents at the xanthine 7-position were tolerated.
• 7-Methyl analogues showed increased A2 vs A1 selectivity compared to 7-H analogues.
• Specific substitutions on the phenyl ring and alkyl groups influenced potency and selectivity.
• 1,3,7-Trimethyl-8-(3-chlorostyryl)xanthine demonstrated high A2 selectivity (520-fold).
• A water-soluble derivative, 1,3,7-Trimethyl-8-[(3-carboxy-1-oxopropyl)amino]styryl]xanthine, showed high A2 selectivity (250-fold).
• 1,3-Dipropyl-7-methyl-8-(3,5-dimethoxystyryl)xanthine was a potent (Ki = 24 nM) and selective antagonist.

Conclusions:

• Substituted 8-styryl-1,3,7-alkylxanthines are effective A2-selective adenosine receptor antagonists.
• Structural modifications can optimize potency, selectivity, and pharmacokinetic properties.
• These compounds represent promising leads for developing therapeutics targeting adenosine receptor-mediated conditions.